DEINOVE announced that the Board of Directors of the Company has acknowledged Emmanuel Petiot's decision to resign as CEO of DEINOVE and has decided, in consultation with Emmanuel Petiot, that his duties will end on 31 December 2019. Dr. Charles Woler, currently Chairman of the Board of Directors of DEINOVE, has been appointed interim CEO as of 1st January 2020. The Board of Directors has already begun the process of recruiting a new CEO to pursue the Company's high-potential activities' development, and in particular the upgrading of its research and development services.

In order to facilitate the transition and support its current and future scientific and industrial partnerships, the Company's Board of Directors has co-opted Emmanuel Petiot as a director to replace Bernard Fanget, who has resigned.